Aesthetic Medicine at the Luxury Standard: Beyond the LaserAway Model
Luxury-standard aesthetic medicine differs from the chain-clinic model on four axes: who performs the procedure (physician vs. midlevel-only), how the device or injectable is selected (clinical fit vs. distribution deal), how outcomes are tracked (longitudinal photography and patient-reported outcomes vs. nothing), and how the patient experience is governed (clinical standard vs. retail conversion).
The dominant aesthetic-chain model in the United States is structured around volume, midlevel delivery, and conversion-optimized retail design. There is a real audience for that model and a real role for it inside the broader market. But it is not the standard ZMD Group is being built around.
In our aesthetic medicine brand, every surgical procedure is performed by a board-certified physician; every device and injectable on the menu has earned its place through clinical fit and outcomes data, not through a manufacturer's volume agreement; outcomes are tracked longitudinally with standardized photography and patient-reported measures; and the design of the patient experience — from first consultation through post-procedure follow-up — is owned by the clinical team rather than by a retail-marketing function.
Written for ZMD Group Editorial. Inquiries: [email protected].